Immune Checkpoint Inhibitors and the Heart

Immune Checkpoint Inhibitors and the Heart

Immune checkpoint inhibitors (ICIs) represent a break-through treatment for a large number of cancer types. This treatment is increasingly being recommended. ICIs are prescribed for primary tumours and for metastases, adjuvant/neo-adjuvant therapy. Thus, there is an increased need for expertise in t...

Full description

Bibliographic Details
Main Authors: Diana Larisa Mocan-Hognogi, Sebastian Trancǎ, Anca Daniela Farcaş, Radu Florin Mocan-Hognogi, Andrada Viorica Pârvu, Anca Simona Bojan
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-09-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
immune checkpoint inhibitors
chemotherapy
cardiotoxicity
immune-related adverse events
cancer
CTLA-4
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2021.726426/full

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2021.726426/full

Similar Items